Future Microbiology · 2019 · 47 citations · 37 references
Life SciencesInfectious DiseasesMicrobiologyBacteriologyMedical MicrobiologyPediatric Infectious DiseasesAntibiotic ResistanceBacterial IdentificationBacterial InfectionsCarbapenem ResistanceDiagnostic BacteriologyPathogen DetectionAcinetobacter Baumannii ResistanceBeta-lactamase GenesCarbapenem AntibioticsDna Hybridization DetectionKlebsiella Pneumoniae CarbapenemaseMolecular Typing Of BacteriaMultilocus Sequence AnalysisNew Delhi Metallo-beta-lactamase
Aim: To determine the prevalence of New Delhi metallo-β-lactamase (NDM)-producing Gram-negative pathogens isolated from children’s samples. Materials & methods: Carbapenem-resistant clinical isolates (n = 117) were confirmed by VITEK® 2 compact system, matrix-assisted laser desorption ionization–time of flight and multilocus sequence typing. MIC (μg/ml) of various antibiotics was determined by VITEK 2 compact system. Molecular characterization of the isolates was performed by PCR, DNA sequencing, PFGE and DNA hybridization. Results: Out of 117 carbapenemase producers, 37 (31.6%) and 29 (24.7%) were Klebsiella pneumoniae and Acinetobacter baumannii, respectively. 72 (61.5%) isolates were NDM positive and among these 60, 9 and 3 were NDM-1, -5 and -7, respectively. Majority of the NDM-producing K. pneumoniae belonged to ST11 and ST273 while most of the Escherichia coli belonged to ST405 and ST101. blaNDM were mainly located on 150kb plasmids. MIC displayed high resistance against β-lactams drugs including carbapenems, and the most sensitive drugs were tigecycline and colistin. Conclusion: Dissemination of blaNDM-producing pathogens, particularly in children clinical settings, is a matter of great public health concern.
37
Kanimozhi Kumarasamy, Mark A. Toleman, Timothy R. Walsh et al. · The Lancet Infectious Diseases · 2010 · 2.9K citations · Full text
Dongeun Yong, Mark A. Toleman, Christian G. Giske et al. · Antimicrobial Agents and Chemotherapy · 2009 · 2.4K citations · Full text
Timothy R. Walsh, Janis Weeks, David M. Livermore et al. · The Lancet Infectious Diseases · 2011 · 1.2K citations · Full text
Julie Knoll Rajaratnam, Jake R Marcus, Abraham D. Flaxman et al. · The Lancet · 2010 · 908 citations · Full text